Cargando…
Steroid treatment for COVID-19: Suitable dose and patients
Autores principales: | Hashim, Zia, Nath, Alok, Tripathy, Naresh K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553781/ https://www.ncbi.nlm.nih.gov/pubmed/37787370 http://dx.doi.org/10.4103/lungindia.lungindia_233_23 |
Ejemplares similares
-
High-dose steroids for the treatment of severe COVID-19
por: Piccica, Matteo, et al.
Publicado: (2021) -
High-dose steroids for the treatment of severe COVID-19: comment
por: Tanaka, Shuichi, et al.
Publicado: (2021) -
Inflammatory pseudotumor of the lung with complete resolution
por: Nigam, Neha, et al.
Publicado: (2021) -
Role of low-dose tissue plasminogen activator in patients with refractory hypoxia due to presumed microthrombi in pulmonary vasculature in coronavirus disease 2019: A case series and review of the literature
por: Hashim, Zia, et al.
Publicado: (2022) -
Vigilance in selection of low-dose versus high-dose steroids in COVID-19
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2021)